Cyclofin contains two active ingredients: 200 mg/ml of the anti-inflammatory flunixin-meglumine (eq. to 33.2 mg/ml flunixin meglumine) and 300 mg/ml of the class D anti-infective, oxytetracycline (eq. to 323.5 mg/ml oxytetracycline trihydrate).
Dechra says Cylofin acts within 24-36 hours and has sustained anti-bacterial activity for five to six days following a single intramuscular injection.
Administration is deep intramuscular injection in cattle and Cyclofin has a 35-day withdrawal period and a memorable dose rate of 1 ml per 10 kg body weight.
Alana McGlade MRCVS, national sales manager at Dechra, said: “BRD is one of the most prevalent and costly diseases on farm and early administration of an effective and fast-acting NSAID/antibiotic combination treatment, such as Cyclofin, can help relieve discomfort and stress, alleviate pain and improve demeanour and food intake.”
Cyclofin is available in 100ml vials.
https://www.dechra.co.uk/products/livestock/prescription/cyclofin#Cyclofin-300mg-ml.
Super early bird tickets are available till 28th May.
Rose’s programme recommendations are:
BEVA Congress programme will be embracing the overarching theme of “use it wisely or lose it forever”, chosen by BEVA President Bruce Bladon.
Bruce said: “Antibiotics is an issue which goes so far beyond equine practice and is one of the genuine threats to humanity.
"We must use these precious and finite resource wisely, or, quite reasonably, regulators will prevent us having access to them.
“But this theme resonates further, to the “social licence” which threatens the future of equine sport.
"Rather than platitudes about horse welfare, we now need to show the positive steps we can take to minimise equine injury.
"We need to be developing screening programmes and to be instrumental in safety programmes.
"Otherwise, we may lose equestrian sport forever.”
Individual super early bird BEVA members prices for a three-day pass are £539 for vets for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on 28 May 2025.
http://www.bevacongress.org
CEVA Animal Health, manufacturer of pheromonatherapy products, D.A.P.® and Feliway®, has launched a new website - http://www.petfireworkfear.co.uk/ - and a new leaflet and waiting room poster to support its ‘Remember, remember your pets this November' campaign which is backed by the PDSA, FAB (Feline Advisory Bureau), the APBC (Association of Pet Behaviour Counsellors) and Sound Therapy 4 Pets.
The website features a comprehensive range of information including hints and tips on preparing pets for the firework festivities, how to spot signs of stress in cats and dogs, what to do if pets go missing or are injured, fireworks and the law and information on pheromonatherapy.
"The new site is a one stop shop for information on how to look after pets during the firework season and the precautions that owners should take to help pets cope with their fear of loud noises," says Lucy Brett, product manager at CEVA Animal Health. "Veterinary practices can help highlight these precautions by linking their websites to the ‘Remember, remember your pets this November' site."
A downloadable PR toolkit is also available from the website to enable veterinary practices to highlight the campaign to local pet owners. To request a copy of the ‘Remember, remember your pets this November' information pack, which includes details on CEVA's ‘Promote Your Practice' competition, please call Lucy Brett at CEVA on 01494 781510.
Hill's has added to its range of Science Plan Snacks with a large biscuit size, big bag version for large breed dogs. The 400 gram packs are available as Large Breed Light and Large Breed Healthy Mobility Snacks at a launch price of £2.49 (normal recommended retail price £4.99).
The company says that this follows fantastic feedback from veterinary practices about Science Plan Snacks, and requests for more variants tailored to fit the needs of their client's pets.
The Science Plan snack range offers products across five areas of functionality which, according to Hill's, have proven to be highly motivating for clients: light, immunity support, healthy mobility, oral care and skin & coat. There are adult variants across the range and puppy variants in immunity support and skin & coat.
For further information, please contact your Hill's Territory Manager or Hill's customer service on 0800 282438.
The RCVS Council has announced its agreement with wholesale reform of the College’s governance arrangements to improve the efficiency and accountability of its decision-making processes.
The changes agreed by Council included almost halving the number of Council members and formalising lay and veterinary membership.
Under the proposals approved by Council it would be reduced to 24 members – comprising 13 elected veterinary surgeons (constituting a majority of Council), six appointed laypeople, three members appointed on behalf of the UK veterinary schools and two veterinary nurses. There would also be the option to appoint an additional member on behalf of any allied professions that RCVS Council may choose to regulate as associates of the College.
Professor Stuart Reid, Senior Vice-President of the RCVS and Chair of the Governance Panel that developed the recommendations, said: "I am delighted that Council so fully supported our proposals for a new structure. The new composition will ensure that both veterinary nurses and laypeople have a guaranteed place at the Council table, as well as maintaining a majority of elected veterinary surgeons and important input from the veterinary schools.
"The proposal recognises the unique nature of the RCVS and will allow us to expedite our decision-making process, making us more fleet of foot and better able to respond to the needs of the profession and the public. It has also been constructed to allow Council to evolve its position, ensuring it remains relevant into the future. If all goes well we hope that the changes could come into force as soon as March 2017."
Liz Cox, the Chair of VN Council, particularly welcomed the changes in respect of veterinary nursing representation on RCVS Council, adding: "It is an historic decision for veterinary nurses and one that has been long awaited. It is only right that those who work so closely alongside veterinary surgeons in practice should have a direct input into regulation that affects us all."
Council’s approval of the recommendations was the culmination of two years of debate and consultation with the profession and other stakeholders. This included a formal consultation by the Department for Environment, Food and Rural Affairs (Defra) last year which garnered 52 responses – including from the British Veterinary Association - most of which were supportive. Different options for reform had, in turn, been developed by a Governance Panel, chaired by Professor Reid, which was set up by Council in March 2015 to consider various options.
Defra will now run a short informal consultation to provide those who responded to the initial consultation the opportunity to comment on the proposed reforms. If no issues are raised Defra officials will seek approval from the Government to proceed with a legislative reform order (LRO) to make the necessary changes to the Veterinary Surgeons Act.
This LRO will be scrutinised by parliamentary committee and voted on in both the House of Commons and House of Lords. Once this has been passed there will be a three-year transitional period, agreed by Council members, during which Council’s numbers would be gradually reduced.
Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already widely used in human medicine. It is increasingly being used in the treatment of horses.
The Osteokine system, developed by German company Orthogen which also manufactures joint therapy Irap, comprises two interconnected blood bags.
The system involves taking citrated whole blood from the horse and placing it into the first, red-capped Osteokine bag for processing in a centrifuge. The plasma and platelets are then transferred to the second bag, and a second centrifuge process separates the plasma and generates a pellet of PRP, which is extracted and used to treat the horse from which it was taken.
Treatment with PRP has been shown to accelerate wound healing in all kinds of tissue particularly tendons and ligaments and has also been used in bone healing. It has been noted to reduce perioperative traumatic pain while the higher collagen content provided by PRP can create improved scar resistance.
Commenting on the launch of the Osteokine system in the UK, Rob Watkins, Marketing Director of Genitrix, said: "Therapeutic care of equine lameness is an area of particular expertise for Genitrix and the innovative treatments we've brought to market, including Acell, HY50 and Irap already form part of the staple ‘toolkit' of many equine vets.
"The benefits of PRP in terms of accelerating wound healing and vasculerisation are already widely accepted as are the advantages of an autologous approach in terms of eliminating the risk of disease transmission. To date, however, the process of extracting PRP has proved complex and expensive and only provided in specialised laboratories.
"Osteokine, in contrast, offers a cost-effective approach based on a system which is simple to operate in practice and takes only 20 minutes. We believe it offers a highly effective approach to treating wounds and injuries in horses."
For further information on Osteokine, contact Genitrix on 01403 786345.
Dechra Veterinary Products has announced the appointment of Bob Parmenter as managing director of its UK business.
Commenting on his appointment, Bob said: "I'm pleased to have joined Dechra at a very exciting stage of the company's development. I've been following the growth of Dechra over recent years and with its acquisition of VetXX in January, I believe that the business is now strongly placed to further establish itself as a leading player in the animal health industry."
Having spent nearly 40 years in the industry, Bob Parmenter has previously worked for Schering-Plough, Mallinckrodt Veterinary, Pitman-Moore, Coopers Animal Health and ICI Pharmaceuticals. "My career path has enabled me to experience all aspects of the animal health market. I'm confident my industry-wide knowledge will provide Dechra with additional experience as we continue to build our reputation and strengthen our UK market position."
Former MD Giles Coley, who joined Dechra in 1999 and has managed the UK business since 2003, has been promoted to European Pharmaceutical and Export Sales Director. As a member of Dechra Veterinary Product's European Board he will be responsible for co-ordinating pharmaceutical sales across Europe and developing the company's export sales.
Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin®) compared with a commonly used ACE inhibitor.
The results of the QUEST trial, the largest international study of its kind to be conducted amongst dogs with congestive heart failure, are due to be published in the Journal of Veterinary Internal Medicine (JVIM) later this year.
The condition myxomatous mitral valve disease (MMVD) accounts for approximately 75% of all cases of CHF in dogs2. MMVD is associated with the thickening of the cusps of the mitral valve (one of the main one-way valves within the heart), affecting the flow of blood from the heart to the rest of the body. Although there is no cure for CHF due to MMVD, there are treatments available to manage the condition, improving the quality and length of the dog's life.
Professor Jens Häggström, lead investigator of the QUEST trial from the University of Uppsala, Sweden, commented that "the QUEST trial is a significant milestone in our efforts to reassure both, veterinarians and dog owners, that there is compelling evidence to show that pimobendan is an effective treatment for CHF that prolongs their dog's life and providing pet and owner with more quality time together."
The QUEST trial was a randomised, positive-controlled, multi-centre trial conducted at 28 sites across 11 countries, and is the largest study of its kind ever conducted in veterinary cardiology. The study compared a pimobendan group with a group treated with benazepril hydrochloride on top of background diuretic therapy. The trial spanned three years and followed dogs to death, euthanasia or treatment failure leading to withdrawal from the trial.
Research by Boehringer has also shown that over 50% of dog owners in the UK are unaware that their dog may be at risk of heart failure. Heart disease affects one in four dogs over seven years of age, and the lack of knowledge about this serious, life-threatening condition suggests that there is a need for better education amongst dog owners on how to recognise the disease, and how to maintain their dogs' heart health.
Vygon Vet, a division of Vygon (UK) Ltd, has announced the launch of its website - www.vygonvet.co.uk.
Vygon has been supplying the veterinary market for 15 years. The new website means the company's products can now be bought direct online. The range includes: Vascular Access, IV Management, Needle-Free Devices, Respiratory, Digestive Tract, Regional Anaesthesia, Tissue Adhesive, Urinary & Rectal Tract and Theatre Products.
In addition to product information and technical data, the website offers guidance notes and tips about basic procedures.
Les Davies, Managing Director of Vygon (UK) Ltd said: "The launch of the new website demonstrates our commitment to the veterinary market and we hope that it not only enables veterinary professionals to order our products with ease, but that they also find the guidance notes and advice a valuable resource for their practice."
Vygon Vet products can also be ordered by telephone or through your veterinary wholesaler.
Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.
The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".
Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.
Each 'Facing Up To Finances' discussion will include tips from a financial professional and live Q&A from the community.
Hosted by a member of VetYou, the panel will include a financial professional, a guest sharing their experience, and a member of the Veterinary Woman team.
Registrants can pre-submit questions or ask them live, including anonymously.
Editor of Veterinary Woman, Jenny Langridge, said: “Readers of Veterinary Woman ranked ‘finances’ as the top subject they needed to know more about to make the most of future opportunities.
"It’s vital that women in the veterinary professions are able to access trusted resources such as the Facing Up To Finances discussions to help achieve their financial goals.”
Further sessions in October 2024 and January and May 2025 will cover subjects including preparing for the unexpected, financial planning and negotiation around life moves such as family, moves and career shifts, and financial strategies for wellness and insurance.
https://www.subscribepage.com/veterinary_woman_finance_series
To get involved, you can use the downloadable fundraising pack, which includes ideas, tips and tricks to help you fundraise.
In return for taking part, your practice will have its logo published on the BSAVA website, and BSAVA PetSavers will promote any fundraising posts on social media, using the hashtag #TeamPetSavers.
Shelby Tunstall, Fundraising Coordinator for BSAVA PetSavers said: “We are really delighted to be launching this campaign which will help PetSavers fund more research projects for companion animals."
If you want to get involved, you're encouraged to register online here, or contact Shelby Tunstall, Fundraising Coordinator at petsaversadmin@bsava.com.
https://www.bsava.com/petsavers/get-involved/petsaversinpractice.
The day will be led by Sonya Miles, BVSc CertAVP (ZM), CertAqV, MRCVS, RCVS Recognised Advanced Practitioner in Zoological Medicine and WAVMA Certified Aquatic Species Veterinarian.
Lectures will look at techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques in a wide variety of exotic species.
Delegates will also be provided with lecture notes, a CPD certificate, refreshments and lunch, as well as goodie bags provided by sponsors Pinmoore Animal Laboratory Services Limited.
Sonya says the aim of the day is to dispel many myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
To book your place or for more information, email: info@justexotics.co.uk or book online at https://justexoticsevents.co.uk/dont-miss-out-on-our-latest-event
Reasonable adjustments can include changing working arrangements and providing equipment, services and support.
The campaign will address common myths and misconceptions surrounding reasonable adjustments and highlight the legal obligations of leaders and managers around implementation.
The campaign, which will run until the end of July, is being launched after an RCVS/British Veterinary Chronic Illness Support (BCVIS) survey concluded there is a need to increase awareness about reasonable adjustments, promote wider discussion and equip organisations with the information they need to implement them.
The research also indicated that improved knowledge of legislation is needed, with communication also being raised as an important issue, so that individuals feel empowered to ask for the support they need.
MMI Lead, Rapinder Newton, said: “Our ‘Let’s talk adjustments’ campaign will support people to have these important conversations by sharing information, educational resources and guidance on good practice.
"It will also provide examples of different types of adjustments, including examples that are specific to the veterinary context.
“We know that physical and mental health are deeply interconnected.
"Reasonable adjustments can support both physical and mental health but also helps to safeguard mental health through allowing individuals with disabilities to thrive.
“We will be keeping people updated on the campaign, which has its own dedicated section on the RCVS website, via the RCVS social media channels, as well as providing information in RCVS newsletters, so do keep an eye out for this over the coming months.”
https://www.rcvs.org.uk/lifelong-learning/leadership-diversity-and-inclusion/reasonable-adjustments-campaign/
Photo courtesy: https://depositphotos.com
Vets Now, the out-of-hours emergency services provider is to launch the Vets Now Hospital service in Glasgow city centre, where it will offer emergency and critical care together with a range of specialist referral options.
This follows on the heels of The University of Glasgow Small Animal Hospital, a new £15 million facility which opened at the end of August.
Vets Now says that the new hospitals and the range of clinical services on offer to the profession and pet owners will make the west of Scotland a centre of excellence in advanced clinical care for animals.
The opening of the two facilities will also offer both organisations a new platform on which to develop further their long standing relationship through future collaboration in the areas of teaching, training and investigation into animal disease.
Vets Now Group Managing Director, Richard Dixon said: "The opening of the two facilities presents a number of opportunities for both organisations to work collaboratively to develop teaching and training for undergraduates, residents, interns and nurses, and to work together to gain further understanding into animal disease through clinical investigation and the practice and promotion of evidence based medicine."
Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University said: "The expanded service which will be offered by the Small Animal Hospital and the new Vets Now Hospital obviously presents an enhanced range of choices for pet owners and first opinion vets in Scotland and an opportunity for both organisations to work collaboratively to ensure that undergraduates and clinical professionals have access to the best training and opportunities to develop professionally. We have enjoyed a mutually beneficial relationship for a number of years and we look forward to the new opportunities which the opening of the two hospitals will bring in the future."
The Small Animal Hospital opened on 31 August. The first Vets Now Hospital will open in Glasgow on 31 October.
The Blue Cross is to be the first animal charity to star in a BBC Lifeline appeal to help raise funds for animals in need.
Presented by actress Felicity Kendal and her cocker spaniel George, the short film shows the work of the charity which helps thousands of sick and homeless animals every year.
Felicity Kendal said: "I'm delighted to be able to help publicise the work of this wonderful charity. The Blue Cross does so much to help animals in need and they rely almost entirely on public donations. I hope lots of people watch the BBC appeal to see just where the money goes and why this is a charity worthy of their support."
The BBC Lifeline appeal featuring The Blue Cross will be broadcast on BBC2 on Wednesday 28th October at 2pm.
The film will also be available to view on the BBC website until the end of November at www.bbc.co.uk/lifeline. Thereafter it can be viewed on The Blue Cross website at http://www.bluecross.org.uk/.
Eli Lilly and Company, which owns Elanco Animal Health, has announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in cash.
Lilly says that on completion of the deal, Elanco will be the second-largest animal health company in terms of global revenue. It will also solidify its number two ranking in the U.S., and improve its position in Europe and the rest of the world.
As part of the agreement, Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees.
The transaction is expected to be completed by the end of the first quarter of 2015, subject to clearance under the U.S. Hart-Scott-Rodino Antitrust Improvements Act, similar requirements outside the U.S., and other customary closing conditions.
John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer said: "Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses.
"Significant investments in our animal health business in recent years have enabled Elanco to double its revenue since 2008, leading the industry in growth. Global trends suggest continued sustained demand for animal health products in the years ahead. Through this acquisition, which moves Elanco to top-tier in the industry, we intend to create value for our shareholders by adding to our promising pipeline of innovative animal health assets, increasing sales through a larger commercial footprint, and improving efficiencies and lowering costs."
Bayer Animal Health, the maker of Veraflox, has produced a new animation which explains the considerations veterinary surgeons should take into account when choosing which antibiotic to prescribe.
The animation outlines the key steps that should be taken when faced with a suspected bacterial infection and includes factors such as culture and sensitivity testing, resistance and the mutant prevention concentration.
The company says it produced the animation in response to research it carried out last year in which nearly 500 veterinary professionals (465 practising vets and 45 students) participated.
48% said they felt that not enough is being done to educate veterinary professionals on the responsible use of antibiotics and how to avoid exacerbating the urgent issue of antimicrobial resistance.
Vicky McAlister, Group Product Manager at Bayer said: "In response to this research Bayer is developing a suite of educational resources to arm vets with practical and applicable tools that help them look beyond the 'tip of the iceberg' of bacterial infections, educating about not just the clinical cure, but bacteriological cure, too."
The animation is part of a wider awareness programme entitled ‘What Lies Beneath‘ in which Bayer says it aims to better understand the challenges the veterinary industry faces when prescribing antibiotics, so that additional tools can be developed to help vets confidently use antibiotics responsibly.
The programme will also include a series of webinars led by experts in various fields including veterinary medicine, laboratory diagnostics experts, behavioural psychologists and microbiologists. The webinars are due to be released later in the year, and will present a different perspective on common issues such as compliance, how to make appropriate antimicrobial choices and the approach to and interpretation of relevant diagnostic tests.
The course will cover reptiles, pet mammals and captive birds.
Marie says the course will teach you how to approach exotic emergencies confidently, from clinical examination and forming differential diagnoses to medical and surgical approaches for common emergency presentations.
Marie will discuss both clinical management and the stabilisation and care of the critical patient, including fluid therapy, analgesia, contra-indicated medications and hospital cage requirements.
Welfare-focused euthanasia approaches will also be covered for different species.
Tickets cost £300 and the course is open to veterinary surgeons, veterinary nurses and students on a recognised veterinary or nursing course.
Lunch, tea, coffee and biscuits included.
https://evolutionexoticsreferrals.co.uk/cpd-booking-form/
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
The Veterinary Laboratories Agency has worked in collaboration with the Institute of Animal Health (IAH) at Pirbright to introduce the Polymerase Chain Reaction (PCR) test for Bluetongue virus.
This test is now available via veterinary surgeons for pre-movement (UK) and export testing purposes only.
As of this date, PCR testing for these purposes will no longer be available from IAH, Pirbright.
For further information see www.vla.gov.uk
.
The Kennel Club has confirmed that the BBC has pulled out of broadcasting Crufts next year.
According to the Kennel Club, the decision was reached following what it described as 'unreasonable demands' from the BBC, including the exclusion of certain breeds of dog from the group competition at the show.
The Kennel Club says the BBC's demands took no account of the measures it has in place to improve the health of pedigree dogs, or of the fact that judges will be trained to help ensure that all dogs being awarded prizes at Crufts will be healthy representatives of their breed.
Ronnie Irving, Kennel Club Chairman, said "I am very sorry that BBC audiences around the world will not be able to join us in celebrating all dogs in 2009 and to see the remarkable diversity of dogs and activities on show at Crufts; ranging from the show classes to agility displays, the Friends for Life competition and the unsung heroes who take part in breed rescue.
"However, we have been forced to reject the insupportable conditions imposed by the BBC, who have told us they will only televise the show in 2009 if certain breeds are excluded from participating.We are unable to agree to these demands, as it would compromise both contractual obligations and our general responsibility to dog exhibitors and our audience and we believe it would be inappropriate and counterproductive to exclude any recognised breed from Crufts.
"We are obviously disappointed and confused with this outcome as we hoped the broadcast would have supported our focus on health and welfare issues, given advice about caring for and training dogs and showcased the charitable work that we support. This TV exposure would have benefited all dogs and given viewers a well-rounded picture of what the new Crufts in 2009 is all about."
In October 2008 the Kennel Club announced a strategy to show how it is focusing its activities on the health and welfare of all dogs. It announced mandatory compliance with a strict code of ethics for all breed clubs registered with the Kennel Club.
Earlier this month, it completed a review for each of the 209 pedigree dog breeds in the UK and announced revised standards that it says will have far-reaching benefits for the health and welfare of dogs. These new breed standards and health plans will benefit from research that has been funded by the Kennel Club in conjunction with veterinary research centres over a number of years. The overall aim is that all pedigree dogs should be fit for function and that breeders and judges should not reward dogs with obvious conditions or exaggerations, which would be detrimental in any way to their health.
The Centre of Applied Pet Ethology (COAPE) has announced that its first students have completed the COAPE Level 4 Diploma in the Principles of Companion Animal Behaviour and Training and the COAPE Level 5 Diploma in the Practical Applications of Companion Animal Behaviour and Training.
The qualifications are the first and currently only Ofqual-regulated qualifications for those working in the field of companion animal behaviour and training, and these are the first students to achieve the new qualification.
COAPE Co-Director, Prof. Peter Neville said "We are enormously proud of the successful students, 35 at Level 4 and 21 at Level 5, and wishes them all the very best as they embark on their professional careers and pursuits in the field of canine and feline behaviour, be it as behaviourists, trainers or adding to their present roles as veterinary nurses, veterinarians, assistance dog trainers, animal welfare professionals etc."
COAPE Co-Director, Robert Falconer-Taylor, BVetMed, DipCABT, MRCVS said "Our successful students are the first to be awarded these bespoke qualifications and to have validation and recognition of their ability to help owners and their pets, and especially those to be referred by veterinary practices. In addition they have the ongoing support, mentoring and CPD opportunities available to them as members of the COAPE Association of Pet Behaviourists and Trainers (CAPBT)".
Val Strong (Co-Director of COAPE) said: "This is a historic moment for both COAPE and our awarding body but more importantly for our students. It is also a landmark step in the field of Companion Animal Behaviour and Training Education that is of vital importance for veterinary practices in helping them identify people who have successfully completed a qualification specifically designed for those working in the field of companion animal behaviour and training.
Practices interested in the qualifications for developing behaviour referrals, or their career enhancement value for nurses, visit: http://www.coape.org